On testing cadence, note that there is no universal evidence-based schedule: the frequency of laboratory monitoring should be individualized according to the therapy being used, underlying medical conditions, treatment response, and current clinical guidelines
Given the scoping nature of the review and the heterogeneity of available evidence, study selection focused on identifying representative and clinically informative literature rather than exhaustive quantitative inclusion
However, the extent of this association is unclear since some studies have reported a 7.6-fold increase in the rate of colorectal cancers in acromegalic patients compared with control groups (275), whereas another study has reported as low as twofold increased risk of colorectal cancer in acromegalic patients (286, 287)
MW: 817.9 g/mol (also known as Pralmorelin or Growth HormoneReleasing Peptide2) Key Benefits Research and Clinical Studies - Growth Hormone & Hormonal Modulation: Clinical trials in GHdeficient subjects indicate that the CJC1295, Ipamorelin markedly elevates GH secretion via dual activation of the pituitary and hypothalamic pathways
As tacrolimus has a narrow therapeutic window, frequent monitoring of whole blood concentrations in early postoperative settings is essential to optimize dosing
We follow the pure substance principle: 100% quality, mostly free from colorants, preservatives, and technical additives
